https://www.marketscreener.com/quote/stock/PFIZER-INC-23365019/news/Pfizer-Announces-Positive-Top-Line-Results-from-Phase-3-Study-of-ABRYSVO-in-Adults-Aged-18-to-59-a-46394973/?utm_source=telegram&utm_medium=social&utm_campaign=share